First-void urine as an alternative to clinician-collected cervical samples for HPV detection

Current cervical cancer screening methods, such as Pap smears have limitations, resulting in poor attendance in screening programs. Women would prefer easy, and non-invasive techniques that are not clinician dependent.

Urine as a sample type is well-accepted. Additionally, as Human Papillomavirus (HPV), the most common cause of cervical cancer can be detected in urine, this sample has the potential to reach a wider population, especially women who do not participate in screening.

Novosanis’ Colli-Pee^® device allows for standardized, volumetric collection of first-void urine. The device architecture also enables immediate mixing of the sample with a urine preservative, improving the stability of the sample.

Topics include: 

• Why use first-void urine
• Limitations with current cervical cancer screening methods
• Potential of self-sampling methods, including urine sampling
• Colli-Pee^® as a urine collection device

Read more about HPV detection using urine as a sample type